AI detection of breast cancer during surgery
Part of Cancer, Skin clinical trials.
This trial tests a device that analyzes the smoke from surgical tools during breast cancer surgery. Artificial intelligence detects cancer in real time to help doctors remove all the tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with breast cancer that is confirmed by biopsy.
- You are scheduled for breast-conserving surgery (lumpectomy) at Hospital UC.
- You are not pregnant or breastfeeding.
- You do not have an allergy to the BCGC device used in the study.
- You have not taken part in another clinical trial in the past 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an artificial intelligence (AI) model that looks at pictures of breast tissue to find cancer. It may help improve early detection and reduce the need for invasive tests.
This study tests whether an AI tool can predict how well breast cancer responds to chemotherapy given before surgery. Your tumor sample from a needle biopsy will be analyzed to see if the AI's prediction matches your actual treatment outcome.
This study tests an AI system that helps doctors classify breast biopsy results more accurately. It may lead to better treatment decisions for patients with breast abnormalities.
This study tests whether an artificial intelligence (AI) system can better find the small markers placed during breast biopsies using ultrasound images. It may help improve how these markers are detected in the future.
This study tests a new, non-contact thermal camera (thermography) combined with artificial intelligence to find breast cancer. It is designed for women coming for routine screening, high-risk screening, or diagnostic exams, and aims to see if this painless, radiation-free method can help detect cancer earlier.
This trial uses an artificial intelligence model to predict how well breast cancer responds to neoadjuvant therapy (treatment before surgery). It aims to improve treatment planning by analyzing MRI scans taken before and after therapy.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.